Serum insulin-like growth factor (IGF)-II is more closely associated with liver dysfunction than is IGF-I in patients with cirrhosis

Clin Chim Acta. 2000 Apr;294(1-2):169-77. doi: 10.1016/s0009-8981(99)00254-5.

Abstract

The aim of this investigation was to determine the total concentrations of the insulin-like growth factors (IGF-I and IGF-II) in the blood serum of patients with liver cirrhosis and to evaluate their association with the condition. Cirrhosis was alcohol induced (n=27), of viral origin (n=17) or due to combined or other causes (n=21) and was moderate or severe in similar numbers of cases (Child A: n=21; Child B: n=21; Child C: n=23). While serum levels of both peptides were lower in patients than in age-matched healthy subjects (n=81), there was considerable overlap into the lower normal range for IGF-I. Moreover, no correlation between disease severity (Child score) and serum IGF-I was observed. Since a total of 78% of the results for IGF-II were outside the normal range (95% confidence interval) and serum concentrations were correlated with Child score (P=0.007), it is suggested that serum IGF-II concentrations may reflect compromised hepatic function more closely than IGF-I.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Female
  • Hepatitis B, Chronic / blood*
  • Hepatitis C, Chronic / blood*
  • Humans
  • Insulin-Like Growth Factor I / analysis*
  • Insulin-Like Growth Factor I / metabolism
  • Insulin-Like Growth Factor II / analysis*
  • Insulin-Like Growth Factor II / metabolism
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis, Alcoholic / blood
  • Liver Diseases / blood*
  • Male
  • Middle Aged
  • Reference Values
  • Sex Factors

Substances

  • Insulin-Like Growth Factor I
  • Insulin-Like Growth Factor II